Embolic Prevention Systems Market Insights
Embolic Prevention Systems are used during percutaneous cardiac procedures which helps to reduce the complications due to debris released into the bloodstream and causes blockage in small vessels. Embolic prevention systems are designed to remove debris which is dislodge during procedures. Increasing importance of angioplasty and stenting in the treatment of carotid artery disease will further increased the demand of embolic prevention systems. The number of carotid devices, both for stents and embolic prevention systems has risen steadily in the past few years have increase the use of embolic preventions systems which reduces distal embolization during vascular interventions. Embolic stroke is one of the principle risk of carotid artery stenting and embolic prevention systems reduce the risk through proximal or distal occlusion or filtration. Advancement in the carotid artery stenting continues with the introduction of equipment such as embolic protection systems, and improvement in the stent design will fuel the market growth in the near future.
Embolic Prevention Systems Market Dynamics
Rising incidence of cardiovascular disease and neurovascular disease, increasing use of embolic prevention systems (EPS) for carotid stenting increase the demand further propel the growth of Embolic Prevention Systems market. Introduction of technological advanced embolic prevention systems and ongoing research on improving embolic prevention systems is expected to propel the demand and drives the growth of the global embolic prevention systems market over the forecast period. Increasing strategic collaborations among major players is one of the factor which drive the growth of the embolic prevention systems market revenue over the forecast period.
Despite many advantage of Embolic Prevention Systems, some factor which restraint the growth of market include high procedural cost, longer procedural time and lack of adoption especially in under developed and developing countries.
Embolic Prevention Systems Market: Segmentation
The global Embolic Prevention Systems Market is segmented on basis of drug type, distribution channel and geography.
Embolic Prevention Systems Market: Overview
With the innovation in the new technology for the peripheral interventions, less invasive treatment creates a huge opportunity for the embolic prevention systems to propel in the near future. Increasing options for endovascular surgeons and interventions continue to expand with the introduction of embolic prevention systems which further spur the market growth for embolic prevention systems over the forecast period. The innovative options offered by endovascular techniques for safe, less invasive, alternatives to carotid endarterectomy provide ample opportunity for the embolic preventions systems market to grow in the forecast period. The developing medical infrastructure and advanced services in developing and under developed nations is expected to drive the demand for the embolic prevention systems market over a long run.
Embolic Prevention Systems Market: Region-wise Outlook
The North America is expected to dominate and contribute major share in the market for Embolic Prevention Systems, owing to presence of major players and high adoption of new technology. According to CDC, About 610,000 people in the United States die of heart disease every year and coronary heart disease (CHD) is the common heart disease, which kills over 370,000 people annually. Europe accounts for the second largest market share and register healthy growth in the global embolic prevention systems market, due to developed medical infrastructure, favorable reimbursement scenarios and rising research and development in cardiac artery stenting. Asia Pacific is anticipated to show huge potential in the Embolic Prevention Systems market due to increasing adoption of technically advanced devices such as embolic prevention systems, increasing medical tourism and developing medical infrastructure. China is expected to register significant growth in the embolic prevention systems market, due to growing geriatric population who are more prone to cardiac artery disease and rising adoption of technologically advanced devices Latin America and Middle East & Africa are projected to exhibit moderate growth in embolic prevention systems market, due to developing healthcare facilities and growing awareness.
Embolic Prevention Systems Market: Key Players
Some of the key players present in the global embolic prevention systems market are InspireMD Inc., Boston Scientific, W.L. Gore & Associates, Medtronic Plc, and Cardinal health among others.
The report covers exhaustive analysis on,
Regional analysis includes
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.